These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 21159055

  • 1. Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.
    Hamuro A, Saito S.
    Psychogeriatrics; 2010 Dec; 10(4):198-200. PubMed ID: 21159055
    [Abstract] [Full Text] [Related]

  • 2. Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice.
    Hayashi Y, Ishida Y, Inoue T, Udagawa M, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Sameshima T, Kawahara T, Goto I, Shudo K, Kurayama S, Nakamura J, Okahara K, Mitsuyama Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):541-5. PubMed ID: 20184936
    [Abstract] [Full Text] [Related]

  • 3. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D, Barak Y, Mirecky I, Mazeh D.
    Int J Geriatr Psychiatry; 2008 Apr 16; 23(4):393-400. PubMed ID: 17879256
    [Abstract] [Full Text] [Related]

  • 4. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
    Monji A, Takita M, Samejima T, Takaishi T, Hashimoto K, Matsunaga H, Oda M, Sumida Y, Mizoguchi Y, Kato T, Horikawa H, Kanba S.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar 17; 33(2):308-11. PubMed ID: 19138715
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec 17; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 6. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease.
    Hashimoto M, Yatabe Y, Kaneda K, Honda K, Ikeda M.
    Psychogeriatrics; 2009 Dec 17; 9(4):196-203. PubMed ID: 20377821
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer's disease with behavioural and psychological symptoms of dementia: a preliminary open-label trial.
    Suzuki H, Gen K.
    Psychogeriatrics; 2015 Mar 17; 15(1):32-7. PubMed ID: 25516380
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM, Koumaras B, Chen M, Rabinowicz A, Mirski D.
    Curr Med Res Opin; 2004 Oct 17; 20(10):1605-12. PubMed ID: 15462693
    [Abstract] [Full Text] [Related]

  • 9. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP, Katz IR, Brodaty H, Lyons B, Greenspan A, Burns A.
    Clin Neurol Neurosurg; 2005 Oct 17; 107(6):497-508. PubMed ID: 15922506
    [Abstract] [Full Text] [Related]

  • 10. Risperidone use in Korean patients with Alzheimer's disease: optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living.
    Yoon JS, Kim JM, Lee H, Shin IS, Choi SK.
    Hum Psychopharmacol; 2003 Dec 17; 18(8):627-33. PubMed ID: 14696022
    [Abstract] [Full Text] [Related]

  • 11. Scales to assess efficacy and safety of pharmacologic agents in the treatment of behavioral and psychological symptoms of dementia.
    De Deyn PP, Wirshing WC.
    J Clin Psychiatry; 2001 Dec 17; 62 Suppl 21():19-22. PubMed ID: 11584983
    [Abstract] [Full Text] [Related]

  • 12. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML, Saina M, Trevisiol M, Cristante T, Aguglia E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):205-9. PubMed ID: 17020789
    [Abstract] [Full Text] [Related]

  • 13. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
    Okahara K, Ishida Y, Hayashi Y, Inoue T, Tsuruta K, Takeuchi K, Yoshimuta H, Kiue K, Ninomiya Y, Kawano J, Yoshida K, Noda S, Tomita S, Fujimoto M, Hosomi J, Mitsuyama Y.
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr 16; 34(3):532-6. PubMed ID: 20170698
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Dementia following bipolar disorder].
    Lebert F, Lys H, Haëm E, Pasquier F.
    Encephale; 2008 Dec 16; 34(6):606-10. PubMed ID: 19081458
    [Abstract] [Full Text] [Related]

  • 18. Estrogen replacement therapy: effects on the cognitive functioning and clinical course of women with Alzheimer's disease.
    Levine AJ, Battista M.
    Arch Clin Neuropsychol; 2004 Sep 16; 19(6):769-78. PubMed ID: 15288330
    [Abstract] [Full Text] [Related]

  • 19. Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
    Mauri M, Mancioli A, Rebecchi V, Corbetta S, Colombo C, Bono G.
    Acta Neurol Scand; 2006 Aug 16; 114(2):97-101. PubMed ID: 16867031
    [Abstract] [Full Text] [Related]

  • 20. A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study.
    Dubois B, McKeith I, Orgogozo JM, Collins O, Meulien D.
    Int J Geriatr Psychiatry; 1999 Nov 16; 14(11):973-82. PubMed ID: 10556869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.